Share This Page
Drug Price Trends for NDC 00093-5507
✉ Email this page to a colleague
Average Pharmacy Cost for 00093-5507
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| OLANZAPINE-FLUOXETINE 12-50 MG | 00093-5507-56 | 7.72442 | EACH | 2025-10-22 |
| OLANZAPINE-FLUOXETINE 12-50 MG | 00093-5507-56 | 7.83729 | EACH | 2025-09-17 |
| OLANZAPINE-FLUOXETINE 12-50 MG | 00093-5507-56 | 7.79180 | EACH | 2025-08-20 |
| OLANZAPINE-FLUOXETINE 12-50 MG | 00093-5507-56 | 7.49899 | EACH | 2025-07-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00093-5507
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00093-5507
Introduction
The National Drug Code (NDC) 00093-5507 identifies a pharmaceutical product marketed within the United States. As part of a comprehensive market analysis, understanding this drug's therapeutic profile, market positioning, manufacturing landscape, regulatory environment, and pricing trends is essential for stakeholders—including pharmaceutical companies, healthcare providers, insurers, and investors.
This report evaluates the current market dynamics affecting NDC 00093-5507, providing a forward-looking price projection grounded in economic, clinical, and regulatory factors.
Product Overview and Therapeutic Context
Based on NDC data, 00093-5507 corresponds to a specific pharmaceutical product, possibly a branded or generic drug within a well-established therapeutic class. While precise identification requires cross-reference with the FDA's database, typical NDC structures suggest a multisource product, often in categories such as anti-infectives, cardiovascular agents, or central nervous system drugs.
The drug's therapeutic class influences market size, competitive landscape, and pricing. For example, if the drug is an oncology-related agent, high demand and limited competition generally equate to premium pricing. Conversely, if it belongs to a crowded generics class, price pressures tend to be more intense.
Market Dynamics
1. Clinical Demand and Market Share
Clinical demand hinges upon the drug's approved indications, adoption rates, and existing treatment paradigms. For instance, if NDC 00093-5507 is indicated for a prevalent chronic condition, such as hypertension or diabetes, patient populations are significant, and market penetration could be substantial.
The drug's market share depends on factors such as formulary inclusion, prescriber preferences, and evidence of clinical superiority or cost-effectiveness. New evidence, such as comparative efficacy studies, can influence prescribing patterns rapidly.
2. Competitive Landscape
The landscape involves branded alternatives, generics, biosimilars, and emerging therapies. Patent status and exclusivity periods critically impact pricing. If the product is under patent protection with no close biosimilar competitors, pricing tends to remain stable or increase within regulatory bounds.
Once patent expiry approaches, expect increased competition diminishing prices. The entry of biosimilars or generics can lead to a notable erosion of market share and price reductions.
3. Regulatory Factors
FDA approvals, patent expirations, and exclusivity periods shape the market trajectory. Regulatory hurdles for new indications or formulations can either sustain market dominance or open up opportunities for competitors exploiting alternative delivery mechanisms or formulations.
4. Manufacturing and Distribution Factors
Sourcing, manufacturing capacity, and supply chain resilience influence pricing stability. Disruption in production or raw material shortages can temporarily inflate prices or limit availability.
Current Pricing Trends
Market prices for drugs similar in class and market position exhibit a broad range, influenced mainly by patent status, competition, and therapeutic value.
-
Brand Name Pricing: Premium drugs with exclusive rights often command retail prices above $10,000 per month, especially in specialty therapeutics.
-
Generic Market Pricing: Once generic versions are available, prices often decline significantly, sometimes by 80-90%. Depending on manufacturing costs, prices for generics range between $100-$1,000 per month.
-
Market Trends: Recent years have seen moderate transparency in pricing, with average wholesale prices (AWP) dropping due to increased biosimilar entry and patent challenges.
Note: Without specific product formulation details, precise historical pricing data cannot be deduced. However, considering the broader context of comparable drugs, a mid-range assumption can be made for the coming years.
Price Projection for NDC 00093-5507
Short-Term (1-2 Years)
If the product is still under patent or exclusivity, prices are expected to remain relatively stable, with potential slight increases attributable to inflation, inflation-adjusted pricing, or adjustments based on clinical demand. Annual price hikes for patent-protected drugs average around 3-5% in the U.S., driven by manufacturer pricing policies.
In case of imminent patent expiration, anticipate a gradual 20-30% decline in pricing over two years following generic entry. For products with multiple competitors, price erosion accelerates, with reductions approaching 50% within the first year of generic market entry.
Medium to Long-Term (3-5 Years)
The long-term trajectory will depend heavily on market competition, advances in therapeutic alternatives, and regulatory changes. Potential reimbursement adjustments and cost-effectiveness evaluations may further influence net pricing.
If facing patent expirations, generic competition could push prices down by up to 80-90%, determining a new baseline for market projections.
Overall projection:
- Scenario A (Patent Protected): Prices will likely increase modestly at 3-5% annually, with stability driven by market demand and reimbursement policies.
- Scenario B (Market Entry of Generics): Prices will decline sharply, possibly by 50% in the first year post-generic approval, with further erosion over subsequent years.
Regulatory and Policy Impact
Policy shifts, such as drug importation, price negotiation reforms under Medicare, or increased scrutiny of inflation-based pricing, could substantially alter projections. For instance, recent legislative efforts aim to empower CMS to negotiate prices for certain high-cost drugs, possibly leading to downward pressures on the drug’s price in public programs.
Implications for Stakeholders
- Manufacturers: Should strategize around patent protection periods and consider formulation innovations or expanded indications to extend market exclusivity.
- Payers and Insurers: Must prepare for potential rebates, formulary restrictions, or tiering strategies that can influence net costs.
- Investors: Should monitor patent timelines and regulatory approvals in competitor markets to assess market share volatility and price sensitivity.
- Healthcare Providers: Need to stay informed about formulary updates and cost considerations impacting prescribing behavior.
Key Takeaways
- The market for NDC 00093-5507 is highly dependent on patent status, competitive dynamics, and clinical demand.
- If patent-protected, expect modest annual price increases, potentially reaching 5% before patent expiry.
- Upon patent expiration and generic entry, prices could decline sharply, with potential reductions up to 80% within two years.
- Regulatory actions and policy reforms can significantly influence future pricing strategies.
- For stakeholders, aligning pricing strategies with patent lifecycles and market competition offers the best positioning for maximizing value.
FAQs
1. How does patent expiration affect the price of NDC 00093-5507?
Patent expiration typically leads to increased generic competition, which often causes prices to drop dramatically—sometimes by 80-90%. The exact decrease depends on market competition levels and regulatory approvals.
2. What factors most influence the future pricing of this drug?
Key factors include patent status, market competition, regulatory changes, clinical demand, and reimbursement policies. Pricing may also be affected by manufacturing costs and supply chain stability.
3. How might new therapeutic developments impact this drug's market?
Emerging therapies or biosimilars can erode market share, prompting price reductions. Conversely, new indications or superior formulations can sustain or increase demand and pricing.
4. Are there significant regional price variations for the drug?
Yes. Prices can differ between healthcare systems, regions, and payment models. Reimbursement rates, negotiated discounts, and formulary placements all influence regional pricing dynamics.
5. How should manufacturers strategize in light of patent expiration timelines?
Proactively developing new formulations, seeking additional indications, or filing for new patents can prolong exclusivity. Preparing for price competition involves optimizing supply chains and pursuing strategic partnerships.
Sources
[1] FDA National Drug Code Directory, U.S. Food and Drug Administration.
[2] IMS Health, Pharmaceutical Pricing Data.
[3] Medicare and Medicaid Drug Pricing Reforms, U.S. Department of Health & Human Services.
[4] Recent patent filings and exclusivity reports, U.S. Patent Office.
[5] Industry analyses on biosimilars and generics market impacts, Journal of Health Economics.
More… ↓
